Contact
:
fr
en
IGBMC
Missions
History
Make a donation
Directory
Intranet
Organisation
Laboratory council and scientific councils
News
Latest news
Next events
Prizes and awards
Scientific publications
Defended theses
Life at IGBMC
Job offers
Student Post-Doc Board
Whistleblowing system
Visiting the IGBMC
Research
Departments
Developmental Biology and Stem Cells
Integrated Structural Biology
Functional Genomics and Cancer
Translational Medicine and Neurogenetics
Executive management
Teams
Subgroups
Topics
Cancer
Rare diseases
Regenerative medicine
Scientific publications
Platforms and services
Research facilities
Centre for integrative biology
Institut clinique de la souris
Platforms
Integrated Structural Biology
CytoEast
Phenotypic analysis and cell screening
GenomEast
PluriCell East
Light microscopy
Protéomics
Services
Zebrafish aquatic facility
Rodents house
Baculovirus
Molecular biology and virus
Mediaprep
Training
EUR IMCBio
Internships and thesis
Collaborate with the IGBMC
Access Our Technological Platforms
Our Collaboration Models
Our Research Teams
You Are
IGBMC staff members
Home
IGBMC
Advancing diagnosis and therapy in TAM/STRMK: Novel Biomarker and ORAI1 Inhibition Strategies
Advancing diagnosis and therapy in TAM/STRMK: Novel Biomarker and ORAI1 Inhibition Strategies
Le
May
20 2026
at
08h00
Thèse
Invited by
Johann BOHM
Research team(s)
Pathophysiology of neuromuscular diseases
Location
Auditorium, IGBMC
Speaker(s)
Emma LAFABRIE
Partager
